Dompé Farmaceutici S.p.a
Clinical trials sponsored by Dompé Farmaceutici S.p.a, explained in plain language.
-
Drug trial for severe pneumonia halted early after failing to show benefit
Disease control TerminatedThis study tested whether adding an oral drug called reparixin to standard hospital care could help adults with severe pneumonia or COVID-19. The main goal was to see if it reduced the number of patients who died or needed a breathing machine within 28 days. The trial was stopped…
Phase: PHASE3 • Sponsor: Dompé Farmaceutici S.p.A • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Drug trial aims to slow type 1 diabetes progression
Disease control TerminatedThis study tested whether an oral drug called ladarixin could help preserve the body's remaining insulin-producing cells in people recently diagnosed with type 1 diabetes. About 140 participants, aged 14-45, took either ladarixin or a placebo for one year, followed by another yea…
Phase: PHASE2 • Sponsor: Dompé Farmaceutici S.p.A • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Scientists probe the hidden pain of dry eye
Knowledge-focused TerminatedThis study aimed to understand how Sjögren's-related dry eye affects the nerves and pain sensitivity in the cornea (the clear front of the eye). Researchers observed 103 adult patients, measuring their eye sensitivity and tear production with standard clinical tools and a pain qu…
Sponsor: Dompé Farmaceutici S.p.A • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC